Drugs currently in Phase II clinical trials for cocaine addiction.
about
The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic OptionTopiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trialsRole of Dopamine 2 Receptor in Impaired Drug-Cue Extinction in Adolescent RatsExercise during early, but not late abstinence, attenuates subsequent relapse vulnerability in a rat modelAripiprazole Facilitates Extinction of Conditioned Fear in Adolescent Rats.The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues.Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats.Designing modulators of 5-hydroxytryptamine signaling to treat abuse disorders.Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle.Withdrawal from cocaine self-administration and yoked cocaine delivery dysregulates glutamatergic mGlu5 and NMDA receptors in the rat brain.Topiramate increases the rewarding properties of cocaine in young-adult mice limiting its clinical usefulness.A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trial.
P2860
Q28082830-3202AFBD-48B6-47D7-9195-752E9AE86B88Q28272720-FF67EC1A-6EA0-4124-B340-E088C3D110EAQ28273912-3C0D2F35-B68E-4E19-B635-D70D2C87BEF8Q30276911-693EAC07-4F88-4D1D-8231-98336A16CD4DQ33650040-6453A2C2-D7A4-4149-9CAD-1E7C5EDA6752Q34509746-18049594-83E8-47BB-A0AE-5F86FAAEEB99Q35468865-70557CD4-666D-4A96-A07B-6AB8416A36D3Q36115179-F996C839-562C-4E60-AFD8-AC790A623356Q37656934-1D94599B-3DED-4DB5-8904-772B70EC3B89Q38248774-3756C42C-3B7D-4035-8662-DA59D1472ADEQ38940577-78AE102A-4553-466C-8A5B-50DE0F6EC18EQ43180906-F3F2430F-B8C8-415E-ABBD-F7132B8E3483Q47391660-BA3D839D-888F-4CBC-ACA0-9E81F3AC9A6EQ47551822-FD4AFF3F-4D93-49CF-A0CE-2CA75CDF124F
P2860
Drugs currently in Phase II clinical trials for cocaine addiction.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drugs currently in Phase II clinical trials for cocaine addiction.
@en
type
label
Drugs currently in Phase II clinical trials for cocaine addiction.
@en
prefLabel
Drugs currently in Phase II clinical trials for cocaine addiction.
@en
P2860
P1476
Drugs currently in Phase II clinical trials for cocaine addiction.
@en
P2093
Andrew J Lawrence
P2860
P304
P356
10.1517/13543784.2014.915312
P407
P50
P577
2014-04-29T00:00:00Z